UBC applies an integrated approach to pricing and reimbursement, providing clients with strategic solutions that demonstrate the value of their products, services and delivery mechanisms to key audiences – mainly payers and providers. Our reimbursement staff is skilled in all aspects of coverage and payment for drugs, devices and biologicals, including an in-depth knowledge of Medicare, Medicaid and managed care payers. We help you identify the long-term strategic reimbursement and tactical programs necessary to support your commercialization goals.
We partner with you in the pre-launch phase to assess the reimbursement landscape and develop payer launch strategies & tactics. This full reimbursement & pricing assessment may include:
- Payer mix analyses
- Coverage and payment landscapes
- Coding and billing analyses
- Analogue pricing analyses
- Payer and provider market research
- Advisory boards
- Medicare Part D formulary access analysis
All of this research drives the development of a strategic launch-to-payer plan.